The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Cholinergic Modulation of Locomotion and Striatal Dopamine Release Is Mediated by 6 4* Nicotinic Acetylcholine Receptors
Open accessAbstract
Dopamine (DA) release in striatum is governed by firing rates of midbrain DA neurons, striatal cholinergic tone, and nicotinic ACh receptors (nAChRs) on DA presynaptic terminals. DA neurons selectively express alpha6* nAChRs, which show high ACh and nicotine sensitivity. To help identify nAChR subtypes that control DA transmission, we studied transgenic mice expressing hypersensitive alpha6(L9'S)* receptors. alpha6(L9'S) mice are hyperactive, travel greater distance, exhibit increased ambulatory behaviors such as walking, turning, and rearing, and show decreased pausing, hanging, drinking, and grooming. These effects were mediated by alpha6alpha4* pentamers, as alpha6(L9'S) mice lacking alpha4 subunits displayed essentially normal behavior. In alpha6(L9'S) mice, receptor numbers are normal, but loss of alpha4 subunits leads to fewer and less sensitive alpha6* receptors. Gain-of-function nicotine-stimulated DA release from striatal synaptosomes requires alpha4 subunits, implicating alpha6alpha4beta2* nAChRs in alpha6(L9'S) mouse behaviors. In brain slices, we applied electrochemical measurements to study control of DA release by alpha6(L9'S) nAChRs. Burst stimulation of DA fibers elicited increased DA release relative to single action potentials selectively in alpha6(L9'S), but not WT or alpha4KO/alpha6(L9'S), mice. Thus, increased nAChR activity, like decreased activity, leads to enhanced extracellular DA release during phasic firing. Bursts may directly enhance DA release from alpha6(L9'S) presynaptic terminals, as there was no difference in striatal DA receptor numbers or DA transporter levels or function in vitro. These results implicate alpha6alpha4beta2* nAChRs in cholinergic control of DA transmission, and strongly suggest that these receptors are candidate drug targets for disorders involving the DA system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, expression of a hypersensitive α6 subunit in a bacterial artificial chromosome (BAC) transgenic mouse line potentiates nicotine-induced burst firing in DA neurons, and potentiates nicotine place preference at low doses of nicotine (Drenan et al. 2008a(Drenan et al. , 2010)).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Drenan et al. 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Midbrain dopamine neurons encode a quantitative reward prediction error signal
Bayer, H. M., & Glimcher, P. W. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.020 · Cited by 1,304
Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning
Tsai, H.-C., Zhang, F., Adamantidis, A., Stuber, G. D., Bonci, A., de Lecea, L., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1168878 · Cited by 1,266
Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system
Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., & Roeper, J. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.022 · Cited by 976
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Nicotine amplifies reward-related dopamine signals in striatum
Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585
Cited by
Sorted by citations
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366
“In the midbrain, nAChRs comprising the β2 nAChR subunit in combination with α4 and/or α6 subunits are essential for nicotine-induced reinforcement and the DA signal (Drenan et al. 2010, Mameli-Engvall et al. 2006, Picciotto et al. 1998, Pons et al. 2008, Tapper et al. 2004).”
BackgroundDopamine Signaling in Dorsal Versus Ventral Striatum: The Dynamic Role of Cholinergic Interneurons
Threlfell, S., & Cragg, S. J. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00011 · Cited by 200
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
How Can We Use Our Knowledge of Alcohol-Tobacco Interactions to Reduce Alcohol Use?
McKee, S. A., & Weinberger, A. H. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185549 · Cited by 164
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159
Self-citationRole of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 128
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Dopaminergic and cholinergic learning mechanisms in nicotine addiction
Subramaniyan, M., & Dani, J. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12871 · Cited by 110
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97
Guzmán, M. S., Jaeger, X. D., Raulic, S., Souza, I. A., Li, A. X., Schmid, S., Menon, R. S., Gainetdinov, R. R., Caron, M. G., Bartha, R., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001194 · Cited by 99
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 97
Self-citationFunctional roles of neurotransmitters and neuromodulators in the dorsal striatumPreprint
Do, J., Kim, J., Bakes, J., Lee, K., & Kaang, B. (2012) · Learning & Memory · doi:10.1101/lm.025015.111 · Cited by 82
Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4 subtype
Hone, A. J., Meyer, E. L., McIntyre, M., & McIntosh, J. M. (2011) · The FASEB Journal · doi:10.1096/fj.11-195883 · Cited by 76
Self-citationSanjakdar, S. S., Maldoon, P. P., Marks, M. J., Brunzell, D. H., Maskos, U., McIntosh, J. M., Bowers, M. S., & Damaj, M. I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.177 · Cited by 74
Self-citationNair, A. G., Gutierrez‐Arenas, O., Eriksson, O., Vincent, P., & Kotaleski, J. H. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-15.2015 · Cited by 69
Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine
Wang, L., Shang, S., Kang, X., Teng, S., Zhu, F., Liu, B., Wu, Q., Li, M., Liu, W. Y., Xu, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4925 · Cited by 69
α6* Nicotinic Acetylcholine Receptor Expression and Function in a Visual Salience Circuit
Mackey, E. D. W., Engle, S. E., Kim, M. R., O’Neill, H. C., Wageman, C. R., Patzlaff, N. E., Wang, Y., Grady, S. R., McIntosh, J. M., Marks, M. J., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0007-12.2012 · Cited by 63
Self-citationDirect and GABA‐mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones
Luo, R., Janssen, M. J., Partridge, J. G., & Vicini, S. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241786 · Cited by 62
Nicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58
Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q., & Onaivi, E. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.043 · Cited by 62
Buck, J. M., Sanders, K. N., Wageman, C. R., Knopik, V. S., Stitzel, J. A., & O’Neill, H. C. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.006 · Cited by 60
Avelar, A. J., Akers, A. T., Baumgard, Z. J., Cooper, S. Y., Casinelli, G. P., & Henderson, B. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107729 · Cited by 56
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
Neurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 56
Melatonin Protects Against Diazinon-Induced Neurobehavioral Changes in Rats
Ahmed, M. A. E., Ahmed, H. I., & Morsy, E. M. E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1134-9 · Cited by 51
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 55
Self-citationEngle, S. E., Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087346 · Cited by 54
Self-citationAnderson, S. M., & Brunzell, D. H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13090 · Cited by 51
Powers, M. S., Broderick, H. J., Drenan, R. M., & Chester, J. A. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12042 · Cited by 49
Self-citationNicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior
Cohen, B. N., Mackey, E. D. W., Grady, S. R., McKinney, S. L., Patzlaff, N. E., Wageman, C. R., McIntosh, J. M., Marks, M. J., Lester, H. A., & Drenan, R. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.047 · Cited by 50
Self-citationLRRK 2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
Liu, H., Song, L., Ho, P. W., Tse, H., Pang, S. Y., Kung, M. H.-W., Ho, J. W.-M., Ramsden, D. B., Zhou, Z., & Ho, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.45 · Cited by 43
Schilaty, N. D., Hedges, D. M., Jang, E. Y., Folsom, R. J., Yorgason, J. T., McIntosh, J. M., & Steffensen, S. C. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211490 · Cited by 47
Self-citationBrunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Self-citationProgress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 40
Nicotinic Receptor Subtype-Selective Circuit Patterns in the Subthalamic Nucleus
Xiao, C., Miwa, J. M., Henderson, B. J., Wang, Y., Deshpande, P., McKinney, S. L., & Lester, H. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3528-14.2015 · Cited by 39
Self-citationGarção, P., Szabó, E. C., Wopereis, S., de Castro, A. A., Tomé, Â. R., Prediger, R. D., Cunha, R. A., Agostinho, P. M., & Köfalvi, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12234 · Cited by 40
Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release
Acevedo-Rodriguez, A., Zhang, L., Zhou, F., Gong, S., Gu, H. H., Biasi, M. D., Zhou, F.-M., & Dani, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00019 · Cited by 37
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders
Quik, M., Boyd, J. T., Bordia, T., & Perez, X. A. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty063 · Cited by 39
Xiao, C., Srinivasan, R., Drenan, R. M., Mackey, E. D. W., McIntosh, J. M., & Lester, H. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.005 · Cited by 37
Self-citationWickham, R. J., Solecki, W., Rathbun, L. R., McIntosh, J. M., & Addy, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3082-0 · Cited by 36
Self-citationCahir, E., Pillidge, K., Drago, J., & Lawrence, A. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.35 · Cited by 37
Neurochemical organization of the ventral striatum’s olfactory tubercle
Cansler, H. L., Wright, K. N., Stetzik, L. A., & Wesson, D. W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14919 · Cited by 34
Cooper, S. Y., Akers, A. T., & Henderson, B. J. (2020) · eNeuro · doi:10.1523/eneuro.0172-20.2020 · Cited by 35
Mesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34
Levin, E. D., Hao, I., Burke, D. A., Cauley, M. C., Hall, B. J., & Rezvani, A. H. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114543721 · Cited by 34
Zlomuzica, A., Viggiano, D., Degen, J., Binder, S., Ruocco, L. A., Sadile, A. G., Willecke, K., Huston, J. P., & Dere, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.028 · Cited by 34
Richter, F., Gao, F., Medvedeva, V. P., Lee, P. C., Bove, N., Fleming, S. M., Michaud, M., Lemesre, V., Patassini, S., Rosa, K. D. L., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.012 · Cited by 33
Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.014 · Cited by 33
Self-citationBrunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 36
Weinstein‐Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., & Ornoy, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215278 · Cited by 31
Berry, J. N., Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.052 · Cited by 32
Self-citationCholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30
Enhanced synthesis and release of dopamine in transgenic mice with gain‐of‐function α6* nAChR s
Wang, Y., Lee, J., Oh, G., Grady, S. R., McIntosh, J. M., Brunzell, D. H., Cannon, J. R., & Drenan, R. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12616 · Cited by 31
Self-citationAlpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol
Gao, F., Chen, D., Ma, X., Sudweeks, S. N., Yorgason, J. T., Gao, M., Turner, D., Eaton, J. B., McIntosh, J. M., Lukas, R. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.021 · Cited by 34
Self-citationCholinergic system in schizophrenia: A systematic review and meta-analysis
Saint-Georges, Z., MacDonald, J., Al-Khalili, R., Hamati, R., Solmi, M., Keshavan, M. S., Tuominen, L. J., & Guimond, S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03023-y · Cited by 32
Lian, M., Hueffer, K., & Weltzin, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10434 · Cited by 26
Utility of genetically modified mice for understanding the neurobiology of substance use disorders
Fowler, C. D., & Kenny, P. J. (2011) · Human Genetics · doi:10.1007/s00439-011-1129-z · Cited by 30
Cooper, S. Y., & Henderson, B. J. (2020) · Molecules · doi:10.3390/molecules25184223 · Cited by 29
Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 27
The striatal cholinergic system in l-dopa-induced dyskinesias
Perez, X. A., Bordia, T., & Quik, M. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1845-9 · Cited by 25
Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101444 · Cited by 23
Self-citationLocal Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Engle, S. E., Broderick, H. J., & Drenan, R. M. (2012) · Journal of Visualized Experiments · doi:10.3791/50034 · Cited by 24
Self-citationAlfonso, M., Durán, R., Fajardo, D., Justo, L., & Faro, L. R. F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.001 · Cited by 22
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 21
Allon, N., Chapman, S., Egoz, I., Rabinovitz, I., Kapon, J., Weissman, B. A., Yacov, G., Bloch‐Shilderman, E., & Grauer, E. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.03.007 · Cited by 20
Nagy, P. M., & Aubert, I. (2013) · Brain and Behavior · doi:10.1002/brb3.139 · Cited by 21
Steffensen, S. C., Shin, S. I., Nelson, A. C., Pistorius, S. S., Williams, S. B., Woodward, T. J., Park, H.-J., Friend, L. N., Gao, M., Gao, F., et al. (2017) · Addiction Biology · doi:10.1111/adb.12559 · Cited by 18
Self-citationBordia, T., McGregor, M., McIntosh, J. M., Drenan, R. M., & Quik, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.040 · Cited by 17
Self-citationAhnaou, A., Biermans, R., & Drinkenburg, W. H. I. M. (2018) · Neural Plasticity · doi:10.1155/2018/4270263 · Cited by 17
Corrie, L. W.-C., Stokes, C. A., Wilkerson, J. L., Carroll, F. I., McMahon, L. R., & Papke, R. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000037 · Cited by 19
Rasmussen, A., Strøbæk, D., Dyhring, T., Jensen, M. L., Peters, D., Grunnet, M., Timmermann, D. B., & Ahring, P. K. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.024 · Cited by 16
Modulation of Gain-of-function α6*-Nicotinic Acetylcholine Receptor by β3 Subunits
Dash, B., & Lukas, R. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322610 · Cited by 15
Hoestgaard-Jensen, K., Hoestgaard-Jensen, K., & Jensen, A. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509356 · Cited by 15
Dash, B., Li, M. D., & Lukas, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566018 · Cited by 15
Breining, S. R., Melvin, M. S., Bhatti, B. S., Byrd, G. D., Kiser, M. N., Hepler, C. D., Hooker, D. N., Zhang, J., Reynolds, L. A., Benson, L. R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011299 · Cited by 15
A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior
Soll, L. G., Grady, S. R., Salminen, O., Marks, M. J., & Tapper, A. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.001 · Cited by 15
Self-citationGene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission
Peng, C., Yan, Y., Kim, V. J., Engle, S. E., Berry, J. N., McIntosh, J. M., Neve, R. L., & Drenan, R. M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13957 · Cited by 15
Self-citationNicotinic Acetylcholine Receptors of PC12 Cells
Mussina, K., Toktarkhanova, D., & Filchakova, O. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00846-x · Cited by 15
Brain Nicotinic Receptors as Emerging Targets for Drug Addiction
Rahman, S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00008-9 · Cited by 14
Kucinski, A., Wersinger, S., Stachowiak, E., Corso, T. D., Parry, M., Zhang, J., Jordan, K., Letchworth, S., Bencherif, M., & Stachowiak, M. (2013) · Pharmacology, Biochemistry and Behavior · doi:10.1016/j.pbb.2013.07.005 · Cited by 13
Deletion of lynx1 reduces the function of α6* nicotinic receptors
Parker, R. L., O’Neill, H. C., Henley, B. M., Wageman, C. R., Drenan, R. M., Marks, M. J., Miwa, J. M., Grady, S. R., & Lester, H. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188715 · Cited by 14
Self-citationTobacco habits in nocturnal frontal lobe epilepsy
Naldi, I., Bisulli, F., Vignatelli, L., Licchetta, L., Pittau, F., Vito, L. D., Mostacci, B., Menghi, V., Provini, F., Montagna, P., et al. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.10.014 · Cited by 14
Kim, S., Sohn, S., Ryu, I. S., Yang, J. H., Kim, O., Kim, J., Kim, Y., Jang, E. Y., & Choe, E. S. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac063 · Cited by 14
α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption
Kamens, H. M., Peck, C., Garrity, C., Gechlik, A., Jenkins, B. C., & Rajan, A. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.02.178 · Cited by 13
Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain
Peng, C., Engle, S. E., Yan, Y., Weera, M. M., Berry, J. N., Arvin, M. C., Zhao, G., McIntosh, J. M., Chester, J. A., & Drenan, R. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182142 · Cited by 14
Self-citationβ2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats
Walker, N. B., Yan, Y., Tapia, M. A., Tucker, B. R., Thomas, L. N., George, B. E., West, A. M., Marotta, C. B., Lester, H. A., Dougherty, D. A., et al. (2023) · eNeuro · doi:10.1523/eneuro.0449-22.2023 · Cited by 15
Self-citationChen, D.-J., Gao, F.-F., Ma, X., Shi, G.-G., Huang, Y.-B., Su, Q.-X., Sudweeks, S. N., Gao, M., Turner, D., Eaton, J. B., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.209 · Cited by 12
Self-citationLey, C. K.-K., Kuryatov, A., Wang, J., & Lindstrom, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103244 · Cited by 11
Buck, J. M., Yu, L., Knopik, V. S., & Stitzel, J. A. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab138 · Cited by 11
Recent advances in gene manipulation and nicotinic acetylcholine receptor biology
Tammimäki, A., Horton, W. J., & Stitzel, J. A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.014 · Cited by 10
Cardenas, A. M., Bai, Y., Heydary, Y. H., Li, J., Leslie, F. M., & Lotfipour, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063145 · Cited by 12
Collo, G., Cavalleri, L., Zoli, M., Maskos, U., Ratti, E., & Pich, E. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00572 · Cited by 10
Pittel, Z., Lazar, S., Gez, R., & Chapman, S. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.11.002 · Cited by 9
Sandager‐Nielsen, K., Ahring, P. K., Klein, J. L., van Hout, M., Thaneshwaran, S., dos Santos, A. B., Jacobsen, T. A., Amrutkar, D. V., Peters, D., Jensen, A. A., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113786 · Cited by 8
Striatal pathology underlies prion infection-mediated hyperactivity in mice
Gunapala, K. M., Chang, D., Hsu, C. T., Manaye, K. F., Drenan, R. M., Switzer, R. C., & Steele, A. D. (2010) · Prion · doi:10.4161/pri.4.4.13721 · Cited by 8
Self-citationDash, B., & Li, M. D. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-35 · Cited by 8
Metadata
- Authors
- Drenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A.
- Affiliations
- California Institute of Technology (US)
- University of Colorado Boulder (US)
- University of Utah (US)
- Corresponding author
- Lester, H. A.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-07-21
- Volume
- 30
- Issue
- 29
- Pages
- 9877-9889
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3390922
- OpenAlex
- W2010309382
- Cited by
- 127
- References
- 61
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 10 · 2019: 8 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 8 · 2014: 19 · 2013: 14 · 2012: 13
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by-nc-sa)
- Funders
- Ellison Medical Foundation
- Gordon and Betty Moore Foundation
- Tobacco-Related Disease Research Program
- California Institute of Technology
- National Institutes of Health (5t32ns007251-22, AG033954, MH53631, GM 48677)
- National Institute on Aging (R01AG033954, AG033954)
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- National Institute on Drug Abuse (DA-19375, U19DA019375, DA 015663, DA 03194, DA17279, R01DA017279, P30DA015663, F32DA021492, R01DA003194, R01DA012242, DA12242, DA021492)
- National Institute of General Medical Sciences (P01GM048677, GM48677)
- National Institute of Neurological Disorders and Stroke (T32 NS-007251, NS007251)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotinic acetylcholine receptors, alpha4 subunit, striatal dopamine release, locomotion, burst firing, presynaptic terminals, dopaminergic neurons
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Ganglionic Stimulants, Hyperkinesis, Locomotion, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Nicotine, Receptors, Dopamine, Receptors, Nicotinic, Synaptosomes, Mice, Knockout, Dopamine Plasma Membrane Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review